Mayne Pharma Group Ltd has released a press release.
Mayne Pharma launches Butalbital / APAP tablets in the US
Filed with ASX ·
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Mayne Pharma Group Ltd. on 6ix
Earlier from Mayne Pharma
- Mayne Pharma launches Amiodarone 100mg tablets
- Mayne Pharma launches Fabior and Sorilux in the US
- Update on Status of DOJ Investigation
- S&P DJ Indices Announces March Quarterly Rebalance
- MYX launches generic MS Contin (morphine sulfate) tablets
Later from Mayne Pharma
- 2017 Half Year Media Release
- License and supply agreement for generic Nuvaring in the US
- Mayne Pharma acquires rights to generic Duragesic in the US
- Clarification statement
- FDA approval and first generic launch of Acticlate tablets
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma